Literature DB >> 6377287

Hyperkalaemia in diabetes mellitus--potential hazards of coexisting hyporeninaemic hypoaldosteronism.

D M Large, P H Carr, I Laing, M Davies.   

Abstract

Two patients with insulin-dependent diabetes mellitus (Type I), developed severe, life-threatening hyperkalaemia, the first following treatment with spironolactone, the second during treatment for staphylococcal septicaemia when glucose-induced hyperkalaemia occurred. Investigations demonstrated co-existing hyporeininaemic hypoaldosteronism. Prompt recognition of this combined hormone-deficiency syndrome led to appropriate treatment and recovery. The biochemical features and clinical importance of hyporeninaemic hypoaldosteronism are discussed.

Entities:  

Mesh:

Substances:

Year:  1984        PMID: 6377287      PMCID: PMC2417866          DOI: 10.1136/pgmj.60.703.370

Source DB:  PubMed          Journal:  Postgrad Med J        ISSN: 0032-5473            Impact factor:   2.401


  11 in total

1.  Role of hyperkalemia in the metabolic acidosis of isolated hypoaldosteronism.

Authors:  P Szylman; O S Better; C Chaimowitz; A Rosler
Journal:  N Engl J Med       Date:  1976-02-12       Impact factor: 91.245

Review 2.  The defense against hyperkalemia: the roles of insulin and aldosterone.

Authors:  M Cox; R H Sterns; I Singer
Journal:  N Engl J Med       Date:  1978-09-07       Impact factor: 91.245

3.  Isolated hypoaldosteronism in adults. A renin-deficiency syndrome.

Authors:  M Schambelan; J R Stockigt; E G Biglieri
Journal:  N Engl J Med       Date:  1972-09-21       Impact factor: 91.245

4.  Evidence for a role of endogenous insulin and glucagon in the regulation of potassium homeostasis.

Authors:  F Santeusanio; G R Faloona; J P Knochel; R H Unger
Journal:  J Lab Clin Med       Date:  1973-06

5.  Paradoxical glucose-induced hyperkalemia. Combined aldosterone-insulin deficiency.

Authors:  S Goldfarb; B Strunk; I Singer; M Goldberg
Journal:  Am J Med       Date:  1975-11       Impact factor: 4.965

6.  Effect of acute hyperglycaemia on plasma potassium and aldosterone levels in type 2 (non-insulin-dependent) diabetes.

Authors:  J Rosenstock; S A Loizou; I E Brajkovich; K Mashiter; G F Joplin
Journal:  Diabetologia       Date:  1982-03       Impact factor: 10.122

7.  Factors contributing to deaths of diabetics under fifty years of age. On behalf of the Medical Services Study Group and British Diabetic Association.

Authors:  W M Tunbridge
Journal:  Lancet       Date:  1981-09-12       Impact factor: 79.321

8.  Acute hyperkalemia induced by hyperglycemia: hormonal mechanisms.

Authors:  S Goldfarb; M Cox; I Singer; M Goldberg
Journal:  Ann Intern Med       Date:  1976-04       Impact factor: 25.391

9.  Hyporeninemic hypoaldosteronism. An overlooked cause of hyperkalemia.

Authors:  S Y Tan; M Burton
Journal:  Arch Intern Med       Date:  1981-01

10.  Big renin and biosynthetic defect of aldosterone in diabetes mellitus.

Authors:  A deLeiva; A R Christlieb; J C Melby; C A Graham; R P Day; J A Luetscher; P G Zager
Journal:  N Engl J Med       Date:  1976-09-16       Impact factor: 91.245

View more
  4 in total

1.  Interaction of spironolactone with ACE inhibitors or angiotensin receptor blockers: analysis of 44 cases.

Authors:  Eike Wrenger; Regina Müller; Michael Moesenthin; Tobias Welte; Jürgen C Frölich; Klaus H Neumann
Journal:  BMJ       Date:  2003-07-19

Review 2.  The choice of antihypertensive therapy in the diabetic patient.

Authors:  A D Struthers
Journal:  Postgrad Med J       Date:  1985-07       Impact factor: 2.401

3.  Type IV renal tubular acidosis and spironolactone therapy in the elderly.

Authors:  J E O'Connell; N R Colledge
Journal:  Postgrad Med J       Date:  1993-11       Impact factor: 2.401

4.  Hyperkalaemia in diabetes: prevalence and associations.

Authors:  P R Jarman; A M Kehely; H M Mather
Journal:  Postgrad Med J       Date:  1995-09       Impact factor: 2.401

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.